Company Filing History:
Years Active: 2017
Title: The Innovations of Ryan A. Knudson
Introduction
Ryan A. Knudson is an accomplished inventor based in Byron, MN (US). He has made significant contributions to the field of medical research, particularly in the detection of genetic translocations associated with cancer. His work is vital for advancing cancer diagnostics and treatment.
Latest Patents
Ryan A. Knudson holds a patent for his innovative work titled "TBL1XR1 and TP63 translocations." This patent provides methods and materials for detecting translocations of TBL1XR1 and TP63 nucleic acid. Specifically, it includes methods for identifying gene rearrangements associated with cancers, such as T-cell lymphomas. The patent emphasizes the importance of detecting cancers with a dominant negative TP63 phenotype, which can significantly impact patient outcomes.
Career Highlights
Ryan is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to push the boundaries of medical science. His research focuses on the genetic underpinnings of various cancers, contributing to a better understanding of disease mechanisms and potential therapeutic targets.
Collaborations
Ryan has collaborated with notable colleagues, including George Vasmatzis and Andrew L. Feldman. These partnerships enhance the depth and breadth of his research, fostering innovation in cancer diagnostics.
Conclusion
Ryan A. Knudson's work exemplifies the intersection of innovation and medical research. His contributions to the detection of genetic translocations are paving the way for improved cancer diagnostics and treatment strategies.